A. Abed and A. Fezea, “Serum interleukin-6 as an inflammatory biomarker in type 2 diabetes mellitus: correlation with diabetic peripheral neuropathy and diagnostic performance”, RJDNMD, vol. 33, no. 3, pp. 365-372, Sep. 2026.